JP2001501584A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001501584A5 JP2001501584A5 JP1997536327A JP53632797A JP2001501584A5 JP 2001501584 A5 JP2001501584 A5 JP 2001501584A5 JP 1997536327 A JP1997536327 A JP 1997536327A JP 53632797 A JP53632797 A JP 53632797A JP 2001501584 A5 JP2001501584 A5 JP 2001501584A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62960896A | 1996-04-09 | 1996-04-09 | |
| US08/629,608 | 1996-04-09 | ||
| US3226396P | 1996-12-03 | 1996-12-03 | |
| US60/032,263 | 1996-12-03 | ||
| PCT/US1997/005558 WO1997037967A1 (en) | 1996-04-09 | 1997-04-04 | Calcilytic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001501584A JP2001501584A (ja) | 2001-02-06 |
| JP2001501584A5 true JP2001501584A5 (https=) | 2005-01-13 |
Family
ID=26708193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09536327A Ceased JP2001501584A (ja) | 1996-04-09 | 1997-04-04 | カルシリチック化合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6022894A (https=) |
| EP (1) | EP0901459B1 (https=) |
| JP (1) | JP2001501584A (https=) |
| CN (1) | CN1254465C (https=) |
| AR (1) | AR008586A1 (https=) |
| AT (1) | ATE298739T1 (https=) |
| AU (1) | AU726659B2 (https=) |
| BR (1) | BR9708632A (https=) |
| CA (1) | CA2251331C (https=) |
| CO (1) | CO4820431A1 (https=) |
| DE (1) | DE69733649T2 (https=) |
| EA (1) | EA002984B1 (https=) |
| IL (1) | IL126458A (https=) |
| NZ (1) | NZ332068A (https=) |
| PL (1) | PL191027B1 (https=) |
| SA (1) | SA97180135B1 (https=) |
| SG (1) | SG99290A1 (https=) |
| WO (1) | WO1997037967A1 (https=) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| US7202261B2 (en) * | 1996-12-03 | 2007-04-10 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
| UY24949A1 (es) * | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
| WO1999038500A2 (en) * | 1998-01-30 | 1999-08-05 | The Brigham And Women's Hospital, Inc. | The human calcium-sensing receptor in the detection and treatment of cancer |
| US7262280B1 (en) | 1998-04-03 | 2007-08-28 | Nps Pharmaceuticals, Inc. | G-protein fusion receptors and constructs encoding same |
| MY121054A (en) * | 1998-04-08 | 2005-12-30 | Smithkline Beecham Corp | Calcilytic compounds as calcium receptor antagonists. |
| CA2245903A1 (en) * | 1998-09-28 | 2000-03-28 | Mcgill University | Use of pex in the treatment of metabolic bone diseases |
| PE20001456A1 (es) * | 1999-02-02 | 2001-01-28 | Smithkline Beecham Corp | Compuestos calcioliticos |
| CO5180628A1 (es) * | 1999-07-31 | 2002-07-30 | Smithkline Beecham Corp | Compuestos calcioliticos |
| US20030018203A1 (en) * | 2002-07-17 | 2003-01-23 | Largo Maria Amparo | Calcilytic compounds |
| AR030684A1 (es) * | 2000-01-24 | 2003-09-03 | Smithkline Beecham Corp | Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos |
| BR0112600A (pt) * | 2000-07-21 | 2003-06-24 | Smithkline Beecham Corp | Compostos calcilìticos |
| FR2812875B1 (fr) | 2000-08-08 | 2003-12-12 | Centre Nat Rech Scient | Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation |
| DE60136187D1 (de) | 2000-08-11 | 2008-11-27 | Japan Tobacco Inc | Calciumrezeptor-antagonisten |
| AU2002230579A1 (en) * | 2000-10-25 | 2002-05-06 | Smithkline Beecham Corp | Calcilytic compounds |
| CA2481508A1 (en) | 2002-04-12 | 2003-10-23 | Schering Corporation | G-protein coupled receptor ligands and methods |
| US6908935B2 (en) | 2002-05-23 | 2005-06-21 | Amgen Inc. | Calcium receptor modulating agents |
| US7176322B2 (en) | 2002-05-23 | 2007-02-13 | Amgen Inc. | Calcium receptor modulating agents |
| FR2847250B1 (fr) * | 2002-11-15 | 2006-09-22 | Oreal | Composition, notamment cosmetique, comprenant une amine secondaire ou tertiaire |
| TWI316511B (en) * | 2002-11-26 | 2009-11-01 | Smithkline Beecham Corp | Calcilytic compounds |
| WO2004069793A2 (en) | 2003-01-28 | 2004-08-19 | Bristol-Myers Squibb Company | Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| US7205322B2 (en) | 2003-02-12 | 2007-04-17 | Bristol-Myers Squibb Company | Thiazolidine compounds as calcium sensing receptor modulators |
| DK1619180T3 (da) * | 2003-04-23 | 2010-03-29 | Japan Tobacco Inc | CaSR-antagonist |
| WO2004106280A1 (ja) | 2003-05-28 | 2004-12-09 | Japan Tobacco Inc. | ＣａＳＲアンタゴニスト |
| US7265145B2 (en) | 2003-05-28 | 2007-09-04 | Bristol-Myers Squibb Company | Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method |
| WO2005065050A2 (ja) | 2003-12-25 | 2005-07-21 | Asahi Kasei Pharma Corporation | ２環化合物 |
| US20080234370A1 (en) * | 2004-02-06 | 2008-09-25 | Marquis Robert W | Calcilytic Compounds |
| US7648965B2 (en) * | 2004-05-14 | 2010-01-19 | Unigene Laboratories Inc. | Method for fostering bone formation and preservation |
| US7531518B2 (en) | 2004-05-14 | 2009-05-12 | Unigene Laboratories Inc. | Method for fostering bone formation and preservation |
| US8362274B2 (en) | 2004-05-28 | 2013-01-29 | Mitsubishi Tanabe Pharma Corporation | Arylalkylamine compound and process for preparing the same |
| US20080069814A1 (en) * | 2005-01-05 | 2008-03-20 | Novacea, Inc. | Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof |
| KR20080028860A (ko) * | 2005-04-22 | 2008-04-02 | 노바세아, 인크. | 활성 비타민 ｄ 화합물 또는 그의 유사체에 의한 화학 요법또는 방사선 치료와 관련된 폐 장애의 치료, 예방 및 개선 |
| FR2885129B1 (fr) | 2005-04-29 | 2007-06-15 | Proskelia Sas | Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation. |
| US20060293667A1 (en) * | 2005-05-19 | 2006-12-28 | Agnes Vignery | Bone implant device and methods of using same |
| ES2400693T3 (es) | 2005-09-02 | 2013-04-11 | Amgen Inc. | Regulación del equilibrio de fluido intestinal usando calcimiméticos |
| CA2630860A1 (en) | 2005-11-25 | 2007-05-31 | Galapagos Sas | Urea derivatives useful as calcium receptor modulators |
| WO2009055631A1 (en) * | 2007-10-25 | 2009-04-30 | Smithkline Beecham Corporation | Calcilytic compounds |
| RU2502730C2 (ru) * | 2008-06-05 | 2013-12-27 | Асахи Касеи Фарма Корпорейшн | Сульфонамидные соединения и их применение |
| EP2196461A1 (de) | 2008-12-15 | 2010-06-16 | Bayer CropScience AG | 4-Amino-1,2,3-benzoxathiazin-Derivate als Pestizide |
| WO2010103429A1 (en) | 2009-03-10 | 2010-09-16 | Pfizer Inc. | 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists |
| GB201217330D0 (en) | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
| CN103601645B (zh) * | 2013-11-07 | 2016-05-25 | 上海适济生物科技有限公司 | 1-(苯乙基氨基)丙烷-2-醇类化合物或其盐的制备方法 |
| WO2019153216A1 (zh) * | 2018-02-09 | 2019-08-15 | 北京梅尔森医药技术开发有限公司 | 取代芳基胺醇化合物及其制备方法和用途 |
| WO2021110859A1 (en) * | 2019-12-05 | 2021-06-10 | Syngenta Crop Protection Ag | One step process for the preparation of phenyl ethyl amine derivatives |
| CN116199605A (zh) * | 2023-02-27 | 2023-06-02 | 上海睿腾医药科技有限公司 | 一种5-氯-2-羟基-二甲基苯磺酰胺的合成方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE298506C (https=) * | ||||
| GB1129072A (en) * | 1966-02-01 | 1968-10-02 | Ici Ltd | Benzofuran and indole derivatives |
| GB1058822A (en) * | 1963-07-30 | 1967-02-15 | Ici Ltd | 3-amino-2-hydroxypropoxy heterocyclic derivatives |
| GB1199037A (en) * | 1967-09-27 | 1970-07-15 | Ici Ltd | Alkanolamine Derivatives |
| ES410417A1 (es) * | 1973-01-08 | 1976-01-01 | Andreu Sa Dr | Procedimiento para la obtencion de aminoalcoholes derivadosdel p-acetamidofenol. |
| SE388849B (sv) * | 1974-02-14 | 1976-10-18 | Haessle Ab | Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan |
| DE2530613A1 (de) * | 1974-11-01 | 1976-05-06 | Haessle Ab | Aminderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel |
| US4067904A (en) * | 1975-12-19 | 1978-01-10 | Mead Johnson & Company | Alkylsulfonylphenoxypropanolamine derivatives |
| JPS5936617B2 (ja) * | 1976-03-05 | 1984-09-05 | 大塚製薬株式会社 | カルボスチリル誘導体 |
| CH619453A5 (https=) * | 1976-03-17 | 1980-09-30 | Otsuka Pharma Co Ltd | |
| DE2830211A1 (de) * | 1977-07-21 | 1979-02-01 | Sandoz Ag | Substituierte indol-derivate, ihre herstellung und verwendung |
| US4235919A (en) * | 1977-07-21 | 1980-11-25 | Sandoz Ltd. | 1-(Indol-4-yloxy)-3-(2-substituted amino)-2-propanols and pharmaceutical use thereof |
| EP0002792A1 (en) * | 1978-01-03 | 1979-07-11 | Sandoz Ag | 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them |
| DK267779A (da) * | 1978-06-27 | 1979-12-28 | Merck & Co Inc | Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner |
| CH636856A5 (en) * | 1978-07-17 | 1983-06-30 | Sandoz Ag | 4-(3-Aminopropoxy)indole derivatives, their preparation and medicines containing them |
| DE2914166A1 (de) * | 1979-04-07 | 1980-10-23 | Beiersdorf Ag | Arylsubstituierte furane und verfahren zu ihrer herstellung |
| ES480066A1 (es) * | 1979-04-28 | 1980-04-01 | Especialid Latin Medicam Unive | Procedimiento de obtencion de 1-4-cloro-&,&-dimetil-benceno-etanamino-2-oxi-3 ariloxi propanos. |
| DE2943406A1 (de) * | 1979-10-26 | 1981-05-07 | Basf Ag, 6700 Ludwigshafen | Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols |
| DE2944222A1 (de) * | 1979-11-02 | 1981-05-14 | Basf Ag, 6700 Ludwigshafen | Neue aminoderivate des 1,2-benzisothiazols |
| JPS568319A (en) * | 1980-03-26 | 1981-01-28 | Otsuka Pharmaceut Co Ltd | Antihistamine |
| US4332787A (en) * | 1980-06-23 | 1982-06-01 | The Massachusetts General Hospital | Assay for beta-adrenergic antagonists and antibody therefor |
| JPS5780321A (en) * | 1980-11-05 | 1982-05-19 | Otsuka Pharmaceut Co Ltd | Cardiotonic agent |
| US4376125A (en) * | 1980-11-05 | 1983-03-08 | University Of Virginia Alumni Patents Foundation | Aminobenzlpropranolol and pharmaceutical preparation thereof |
| EP0095454A3 (de) * | 1982-05-13 | 1985-04-03 | Gerot-Pharmazeutika Gesellschaft m.b.H. | Neue kernsubstituierte Pyrogallol-Derivate |
| DE3301198A1 (de) * | 1983-01-15 | 1984-07-19 | Hoechst Ag, 6230 Frankfurt | N-arylalkylamin-3-propoxypyridin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung |
| US4517188A (en) * | 1983-05-09 | 1985-05-14 | Mead Johnson & Company | 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols |
| CA1281036C (en) * | 1985-01-15 | 1991-03-05 | Michael D. Dowle | Amine derivatives |
| GB2192394A (en) * | 1986-07-11 | 1988-01-13 | Glaxo Group Ltd | Amine derivatives |
| DK391189A (da) * | 1988-08-10 | 1990-02-11 | Otsuka Pharma Co Ltd | Carbostyrilderivater |
| DE4040186A1 (de) * | 1989-12-20 | 1991-06-27 | Hoechst Ag | Hypoglykaemisch aktive propandiolaminderivate mit insulin-aehnlicher wirkung und deren verwendung, neue propandiolaminderivate, diese substanzen enthaltende pharmazeutische zubereitungen und ihre verwendung zur behandlung von krankheiten |
| DE4017019A1 (de) * | 1990-05-26 | 1991-11-28 | Hoechst Ag | Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen |
| US5409930A (en) * | 1991-05-10 | 1995-04-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| US5763569A (en) * | 1991-08-23 | 1998-06-09 | The Brigham And Women's Hospital, Inc | Calcium receptor-active molecules |
| RU2147574C1 (ru) * | 1991-08-23 | 2000-04-20 | Эн-Пи-Эс Фармасьютикалз, Инк. | Арилалкиламины, композиции, способы лечения и диагностики, способы идентификации соединения |
| CN1192011C (zh) * | 1991-08-23 | 2005-03-09 | Nps药物有限公司 | 对钙受体具活性的芳烷基胺化合物 |
| EP0637237B1 (en) * | 1993-02-23 | 2004-05-19 | Brigham And Women's Hospital, Inc. | Calcium receptor-active molecules |
| GB9312893D0 (en) * | 1993-06-22 | 1993-08-04 | Boots Co Plc | Therapeutic agents |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
-
1997
- 1997-04-04 DE DE69733649T patent/DE69733649T2/de not_active Expired - Lifetime
- 1997-04-04 AT AT97917848T patent/ATE298739T1/de not_active IP Right Cessation
- 1997-04-04 EA EA199800913A patent/EA002984B1/ru not_active IP Right Cessation
- 1997-04-04 IL IL12645897A patent/IL126458A/en not_active IP Right Cessation
- 1997-04-04 BR BR9708632-0A patent/BR9708632A/pt not_active Application Discontinuation
- 1997-04-04 EP EP97917848A patent/EP0901459B1/en not_active Expired - Lifetime
- 1997-04-04 CN CNB971953686A patent/CN1254465C/zh not_active Expired - Lifetime
- 1997-04-04 JP JP09536327A patent/JP2001501584A/ja not_active Ceased
- 1997-04-04 AU AU26070/97A patent/AU726659B2/en not_active Expired
- 1997-04-04 PL PL329314A patent/PL191027B1/pl unknown
- 1997-04-04 CA CA002251331A patent/CA2251331C/en not_active Expired - Lifetime
- 1997-04-04 NZ NZ332068A patent/NZ332068A/en not_active IP Right Cessation
- 1997-04-04 WO PCT/US1997/005558 patent/WO1997037967A1/en not_active Ceased
- 1997-04-04 SG SG9905132A patent/SG99290A1/en unknown
- 1997-04-04 US US08/832,984 patent/US6022894A/en not_active Expired - Fee Related
- 1997-04-08 CO CO97017849A patent/CO4820431A1/es unknown
- 1997-04-09 AR ARP970101400A patent/AR008586A1/es active IP Right Grant
- 1997-06-16 SA SA97180135A patent/SA97180135B1/ar unknown
-
1998
- 1998-08-11 US US09/132,179 patent/US6521667B1/en not_active Expired - Fee Related